Cargando…

Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity

Antiphospholipid antibodies (APLA) are strongly associated with thrombosis seen in patients with antiphospholipid syndrome. In COVID-19, thrombosis has been observed as one of the main comorbidities. In patients hospitalised for COVID-19, we want to check whether APLA positivity is associated with C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alijotas-Reig, Jaume, Anunciación-Llunell, Ariadna, Morales-Pérez, Stephanie, Trapé, Jaume, Esteve-Valverde, Enrique, Miro-Mur, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452204/ https://www.ncbi.nlm.nih.gov/pubmed/37626797 http://dx.doi.org/10.3390/biomedicines11082301

Ejemplares similares

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
por: Alijotas-Reig, Jaume, et al.
Publicado: (2022)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
por: Alijotas-Reig, Jaume, et al.
Publicado: (2020)

TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion
por: Kandhaya-Pillai, Renuka, et al.
Publicado: (2017)

Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex
por: Kandhaya-Pillai, Renuka, et al.
Publicado: (2023)

Immunological and physiopathological approach of COVID-19 in pregnancy
por: Ferrer-Oliveras, Raquel, et al.
Publicado: (2021)

Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review
por: Muñoz, Candido Muñoz, et al.
Publicado: (2022)

Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine–prothrombin complex antibody
por: Yamada, Mai, et al.
Publicado: (2017)

Inflammatory immune‐mediated adverse reactions induced by COVID‐19 vaccines in previously injected patients with soft tissue fillers: A case series of 20 patients
por: Alijotas‐Reig, Jaume, et al.
Publicado: (2022)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19
por: Gomes, Claudia, et al.
Publicado: (2021)

Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
por: Marwah, Vikas, et al.
Publicado: (2021)

Lipidomic profiling in Crohn's disease: Abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition
por: Sewell, Gavin W., et al.
Publicado: (2012)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
por: Mahler, Michael, et al.
Publicado: (2021)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
por: Roselli, Daniele, et al.
Publicado: (2023)

The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014)

Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023)

Atypical memory B-cells are associated with Plasmodium falciparum anemia through anti-phosphatidylserine antibodies
por: Rivera-Correa, Juan, et al.
Publicado: (2019)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
por: Geyer, Chiara E, et al.
Publicado: (2023)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Inverse Phosphatidylcholine/Phosphatidylinositol Levels as Peripheral Biomarkers and Phosphatidylcholine/Lysophosphatidylethanolamine-Phosphatidylserine as Hippocampal Indicator of Postischemic Cognitive Impairment in Rats
por: Sabogal-Guáqueta, Angelica Maria, et al.
Publicado: (2018)

Covid-19 and autoimmunity
por: Ehrenfeld, Michael, et al.
Publicado: (2020)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Protective Effect of Anti-Phosphatidylserine Antibody in a Guinea Pig Model of Advanced Hemorrhagic Arenavirus Infection
por: Thomas, John M., et al.
Publicado: (2017)

Anti-phosphatidylserine antibody levels are low in multigravid pregnant women in a malaria-endemic area in Nigeria, and do not correlate with anti-VAR2CSA antibodies
por: Fasanya, Adebimpe, et al.
Publicado: (2023)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
por: -, -
Publicado: (2020)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases
por: Malíčková, Karin, et al.
Publicado: (2012)

Phosphatidylinositol 3‐monophosphate: A novel actor in thrombopoiesis and thrombosis
por: Valet, Colin, et al.
Publicado: (2020)

Enhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured Macrophages
por: Wang, Ji, et al.
Publicado: (2016)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3nhm4lpgghu8btqnkd61ol2kk4